This suggests that ET-1 specifically may only be altered with clinical manifestations of vascular dysfunction (for example, hypertension); however, the physiological balance of key vasoconstrictors and vasodilators may still be altered in GDM [35], and this warrants further investigation. This evidence concerns the gene EDN1 and hypertensive disorder.